These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32114253)
1. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma. Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253 [TBL] [Abstract][Full Text] [Related]
2. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis. Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791 [TBL] [Abstract][Full Text] [Related]
3. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma. Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470 [TBL] [Abstract][Full Text] [Related]
4. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma. Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276 [TBL] [Abstract][Full Text] [Related]
5. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment. Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179 [TBL] [Abstract][Full Text] [Related]
6. TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan. Zaidi SAA; Chughtai N; Abbassi ZA; Alam J; Malick TS; Salim A; Saleem S BMC Oral Health; 2024 Jul; 24(1):780. PubMed ID: 38992585 [TBL] [Abstract][Full Text] [Related]
7. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis. Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428 [TBL] [Abstract][Full Text] [Related]
8. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis. Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849 [TBL] [Abstract][Full Text] [Related]
9. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma. Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690 [TBL] [Abstract][Full Text] [Related]
10. The association between miR-499a polymorphism and oral squamous cell carcinoma progression. Hou YY; Lee JH; Chen HC; Yang CM; Huang SJ; Liou HH; Chi CC; Tsai KW; Ger LP Oral Dis; 2015 Mar; 21(2):195-206. PubMed ID: 24690080 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis. Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151 [TBL] [Abstract][Full Text] [Related]
12. p16 as an independent marker for detection of high-risk HPV in oral submucous fibrosis and oral squamous cell carcinoma. Sudhakaran A; Hallikeri K; Babu B Indian J Pathol Microbiol; 2019; 62(4):523-528. PubMed ID: 31611434 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases-3 gene-promoter polymorphism as a risk factor in oral submucous fibrosis in an Indian population: a pilot study. Zade PR; Gosavi SR; Hazarey VK; Ganvir SM J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27389714 [TBL] [Abstract][Full Text] [Related]
14. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis. Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434 [TBL] [Abstract][Full Text] [Related]
15. Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis. Xu C; Zhao J; Loo WT; Hao L; Wang M; Cheung MN; Dou Y; Yip AY; Ng EL; Chow LW; Liu Q Int J Biol Markers; 2012 Dec; 27(4):e314-21. PubMed ID: 23250779 [TBL] [Abstract][Full Text] [Related]
16. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island. Li B; Chen X; Xian H; Wen Q; Wang T PeerJ; 2023; 11():e16392. PubMed ID: 38050610 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR; Ranganathan K; Rao UK; Joshua E J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093 [TBL] [Abstract][Full Text] [Related]
18. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis. Chen J; Li W; Liu B; Xie X BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577 [TBL] [Abstract][Full Text] [Related]
19. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis. Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974 [TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis. Choudhari S; Masne S; Bhandare P; Dhumal S J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]